NEUROCRINE BIOSCIENCES INC (NBIX) Shareholders’ equity 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.3BFY2025 · since FY2016: $314.9M → $3.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.3B | +25.6% |
| FY2024 | $2.6B | +16.0% |
| FY2023 | $2.2B | +30.7% |
| FY2022 | $1.7B | +24.3% |
| FY2021 | $1.4B | +22.0% |
| FY2020 | $1.1B | +76.8% |
| FY2019 | $636.9M | +32.5% |
| FY2018 | $480.8M | +29.2% |
| FY2017 | $372.2M | +18.2% |
| FY2016 | $314.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice